Nasdaq · SEC CIK 0001398733
This is the supported SEC-traceable subset, not total insider ownership or personal wealth. Values reflect the current disclosed positions Grizzly Bulls can resolve and value. Latest source filing: Sep 16, 2026 · values through Sep 25, 2026.
Filter the reporting-owner snapshot by holder, role, or security. Position values are shown only where the current reviewed data supports them.
| Holder | Role | Position | Current value | Latest filing |
|---|---|---|---|---|
| Daniel BarberResearch disclosed relationships | President and CEO · Director | 652,317 sharesCommon Stock, par value $0.001 per share | $3.05M | Sep 16, 2026 |
These relationships are joined only when the same single SEC reporting-owner CIK appears unambiguously across the publication-authorized company ownership universe. Name similarity is never used to create a relationship.
SEC reporting-owner CIK 0001742266 · 1 published company relationship
| Company | SEC relationship | Covered position | Current covered value | Latest filing | Research |
|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST)Nasdaq · Current company | President and CEO · Director | 652,317 sharesCommon Stock, par value $0.001 per share | $3.05M | Sep 16, 2026 |
This graph is bounded to the company ownership relationships currently published by Grizzly Bulls. It is not a complete employment, board, ownership, portfolio, or wealth history, and a missing relationship does not establish that none exists.
Each row preserves the reviewed SEC transaction evidence, including the effective-date basis, amendment state, reported post-transaction position when present, and a separately published current covered owner/security position when one can be matched uniquely. Reported price is shown when present. The lab does not calculate gross proceeds, reconstruct balances between filings, or treat historical transactions as current wealth.
| Effective date | Holder | Action | Security | Units | Reported price | Reported position after transaction | Current covered position | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026Transaction date | Daniel BarberResearch disclosed relationships | SaleSEC code S | Common Stock, par value $0.001 per share | 25,000 shares | $4.8195 | 652,317 shares | 652,317 sharesOwner coverage latest filing Sep 16, 2026 | 4Filed Sep 16, 2026 |
| Sep 8, 2026Transaction date | Daniel BarberResearch disclosed relationships | AcquisitionSEC code X | Common Stock, par value $0.001 per share | 91,743 shares | $0.96 | 677,317 shares | 652,317 sharesOwner coverage latest filing Sep 16, 2026 | 4Filed Sep 9, 2026 |
| Aug 17, 2026Transaction date | Daniel BarberResearch disclosed relationships | SaleSEC code S | Common Stock, par value $0.001 per share | 25,000 shares | $4.2867 | 585,574 shares | 652,317 sharesOwner coverage latest filing Sep 16, 2026 | 4Filed Aug 18, 2026 |
| Jul 16, 2026Transaction date | Daniel BarberResearch disclosed relationships | SaleSEC code S | Common Stock, par value $0.001 per share | 20,369 shares | $4.0016 | 610,574 shares | 652,317 sharesOwner coverage latest filing Sep 16, 2026 | 4Filed Jul 17, 2026 |
| Jul 15, 2026Transaction date | Daniel BarberResearch disclosed relationships | SaleSEC code S | Common Stock, par value $0.001 per share | 4,631 shares | $4.0344 | 630,943 shares | 652,317 sharesOwner coverage latest filing Sep 16, 2026 | 4Filed Jul 17, 2026 |
A reported post-transaction position is the balance stated in that historical transaction filing. A current covered position is a separate latest owner/security observation and may reflect later filings or activity. They are shown side by side as evidence points, not as a reconstructed continuous ledger.
Published 5 of 5 source candidates under the current reviewed security-resolution rules.
| Security | Instrument family | Covered positions | Covered value |
|---|---|---|---|
| Common Stock, par value $0.001 per share | ordinary-share | 1 | $3.05M |
Current holdings: direct positions that the reviewed ownership data can trace to an exact reporting owner, legal security, and current-basis quantity.
Current value: the existing published company-position valuation. This lab does not recalculate security values or infer missing positions.
Transaction evidence: historical flow observations with filing provenance. Reported post-transaction balances and current covered positions are separate evidence points; the lab does not interpolate ownership between them.
Reporting-owner graph: exact reporting-owner CIK relationships across the published company universe. It does not merge people by name or create a complete personal history.
Not included here: a claim of total insider ownership, total personal wealth, institutional 13F ownership, a transaction-value estimate, an insider sentiment score, or an investment recommendation.
This sequence orders only the ownership evidence already published by Grizzly Bulls for the exact reporting-owner relationships above. Transaction rows are ordered by filing date while preserving the separate economic effective date and its basis. Current covered snapshots remain separate latest observations.
The chronology does not interpolate ownership between entries, infer missing activity, pair an amended filing with an assumed parent, infer amendment supersession, or treat a current covered snapshot as proof of continuous ownership.
| Evidence date | Company | Observation | Security / position | Source |
|---|---|---|---|---|
| Sep 16, 2026Latest represented filing date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | Current covered snapshotPresident and CEO · DirectorValuation observation Sep 25, 2026 | Common Stock, par value $0.001 per share: 652,317 sharesCurrent covered company value: $3.05M | Published current ownership snapshotForms represented: 4Owner filingsIssuer filings |
| Sep 16, 2026Filed date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | SaleSEC code SEffective Sep 15, 2026 · transaction dateReported units 25,000 shares · reported price 4.8195 | Common Stock, par value $0.001 per shareReported position after transaction: 652,317 shares | 4 filing0001214659-26-011731 |
| Sep 9, 2026Filed date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | AcquisitionSEC code XEffective Sep 8, 2026 · transaction dateReported units 91,743 shares · reported price 0.96 | Common Stock, par value $0.001 per shareReported position after transaction: 677,317 shares | 4 filing0001214659-26-011539 |
| Aug 18, 2026Filed date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | SaleSEC code SEffective Aug 17, 2026 · transaction dateReported units 25,000 shares · reported price 4.2867 | Common Stock, par value $0.001 per shareReported position after transaction: 585,574 shares | 4 filing0001214659-26-010516 |
| Jul 17, 2026Filed date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | SaleSEC code SEffective Jul 15, 2026 · transaction dateReported units 4,631 shares · reported price 4.0344 | Common Stock, par value $0.001 per shareReported position after transaction: 630,943 shares | 4 filing0001214659-26-008663 |
| Jul 17, 2026Filed date | Aquestive Therapeutics, Inc. (AQST)Nasdaq | SaleSEC code SEffective Jul 16, 2026 · transaction dateReported units 20,369 shares · reported price 4.0016 | Common Stock, par value $0.001 per shareReported position after transaction: 610,574 shares | 4 filing0001214659-26-008663 |
Company-level recent transaction history is published for 1 of 1 relationship companies in this graph; 5 published transaction rows for this exact reporting-owner CIK appear in the chronology.
These handoffs preserve the exact company identities already represented in the reporting-owner graph. My Stocks keeps a listed company in your existing research lists. Research Inbox is a separate company-change update workflow.
Saving a company to My Stocks never enables updates, and opening Research Inbox never subscribes you automatically. Each update remains an explicit company-level opt-in under the existing Research Inbox consent flow.
| Company | Reporting-owner context | Published evidence | Continue research |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST)Nasdaq · Current company | Daniel BarberSEC CIK 00017422666 chronology observations | 6Published chronology observationsLatest represented evidence Sep 16, 2026 |
These are company-level continuation paths, not reporting-owner subscriptions. Saving or watching one company does not automatically save or watch the other companies connected to the same reporting owner, and it does not create an owner-level alert.
